Clinical Remission in Severe Asthma

“Biologics can reduce the burden of asthma exacerbations and [oral corticosteroids (OCS)] use in patients with asthma,” write authors of a Commentary on achieving clinical

Read More »

Around the Web — 1.3.23

FDA last week approved ublituximab-xiiy (Briumvi, TG Therapeutics) for treating adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease,

Read More »

PNN JournalWatch — 10.31.22

Lancet: Challenges and Opportunities for Educating Health Professionals After the COVID-19 pandemic Diabetes Care: Automated Insulin Delivery: Benefits, Challenges, and Recommendations. A Consensus Report of

Read More »